BR9815717A - Agentes citostáticos - Google Patents

Agentes citostáticos

Info

Publication number
BR9815717A
BR9815717A BR9815717-5A BR9815717A BR9815717A BR 9815717 A BR9815717 A BR 9815717A BR 9815717 A BR9815717 A BR 9815717A BR 9815717 A BR9815717 A BR 9815717A
Authority
BR
Brazil
Prior art keywords
hydroxycarbamoyl
acid
enoylamino
hex
isobutyl
Prior art date
Application number
BR9815717-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Lindsey Ann Pearson
Andrew Paul Ayscough
Philip Huxley
Alan Hastings Drummond
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of BR9815717A publication Critical patent/BR9815717A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
BR9815717-5A 1998-03-12 1998-03-12 Agentes citostáticos BR9815717A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1998/000754 WO1999046241A1 (en) 1998-03-12 1998-03-12 Cytostatic agents

Publications (1)

Publication Number Publication Date
BR9815717A true BR9815717A (pt) 2000-11-07

Family

ID=10825272

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815717-5A BR9815717A (pt) 1998-03-12 1998-03-12 Agentes citostáticos

Country Status (17)

Country Link
EP (1) EP1062202B1 (https=)
JP (1) JP4324324B2 (https=)
KR (1) KR20010041661A (https=)
CN (1) CN1141292C (https=)
AT (1) ATE231122T1 (https=)
AU (1) AU747977B2 (https=)
BR (1) BR9815717A (https=)
CA (1) CA2323414C (https=)
CZ (1) CZ299610B6 (https=)
DE (1) DE69810817T2 (https=)
GB (1) GB2349149A (https=)
HU (1) HUP0100999A2 (https=)
IL (2) IL137774A0 (https=)
NO (1) NO20004528L (https=)
NZ (1) NZ506293A (https=)
PL (1) PL190637B1 (https=)
WO (1) WO1999046241A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901863D0 (en) 1999-01-29 1999-03-17 British Biotech Pharm Antibacterial agents
WO2019039937A1 (en) 2017-08-21 2019-02-28 Stichting Vumc POLYTHERAPY FOR THE TREATMENT OF CANCER
US10925851B2 (en) 2018-03-15 2021-02-23 Regents Of The University Of Minnesota Use of Tosedostat and related compounds as analgesics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4267293A (en) * 1992-05-01 1993-11-29 British Biotech Pharmaceuticals Limited Use of MMP inhibitors
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
US5691381A (en) * 1995-04-18 1997-11-25 The Dupont Merck Pharmaceutical Company Hydroxamic and carbocyclic acids as metalloprotease inhibitors
IL128337A0 (en) * 1996-09-10 2000-01-31 British Biotech Pharm Cytostatic hydroxamic acid derivatives

Also Published As

Publication number Publication date
NO20004528D0 (no) 2000-09-11
NO20004528L (no) 2000-09-11
CA2323414C (en) 2008-05-13
IL137774A0 (en) 2001-10-31
GB2349149A (en) 2000-10-25
IL137774A (en) 2006-07-05
WO1999046241A1 (en) 1999-09-16
EP1062202B1 (en) 2003-01-15
AU6410698A (en) 1999-09-27
DE69810817D1 (de) 2003-02-20
CN1286681A (zh) 2001-03-07
PL342811A1 (en) 2001-07-02
ATE231122T1 (de) 2003-02-15
KR20010041661A (ko) 2001-05-25
HUP0100999A2 (hu) 2001-08-28
CZ299610B6 (cs) 2008-09-17
CA2323414A1 (en) 1999-09-16
GB0019414D0 (en) 2000-09-27
DE69810817T2 (de) 2003-11-20
AU747977B2 (en) 2002-05-30
JP4324324B2 (ja) 2009-09-02
CZ20003317A3 (cs) 2001-03-14
NZ506293A (en) 2003-05-30
EP1062202A1 (en) 2000-12-27
CN1141292C (zh) 2004-03-10
JP2002506057A (ja) 2002-02-26
PL190637B1 (pl) 2005-12-30

Similar Documents

Publication Publication Date Title
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
NO20004627D0 (no) Aerosolifisert levering av aktive virkemidler
BR9908280A (pt) Inibidores de enzimas de fosfolipase
EP0989857A4 (en) NEW THERAPEUTIC ACTIVE SUBSTANCES THAT INTERRUPT IN ENZYMATIC PROCESSES
FR2825277B1 (fr) Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
PT1066027E (pt) Composicao farmaceutica de topiramato
DK1131416T3 (da) Lipolytiske enzymvarianter
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
MA26818A1 (fr) Formulations contenant des inhibiteurs de lipase
DE69934778D1 (de) Wässrige metallbehandlungszusammensetzung
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
IT1308743B1 (it) Suola di cingolo.
FR2773486B1 (fr) Composition de soin des levres contenant de l'acide acexamique, ses utilisations
DE59910836D1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
BR9815717A (pt) Agentes citostáticos
DE60006799D1 (de) Oralverabreichbare lösung von prucaloprid
BR0012921A (pt) Compostos calcilìticos
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
BR9907697A (pt) Carbonatos de serina
EP1432823A4 (en) MITOCHONDRIAL BIOLOGICAL EXPRESSION ARRAYS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]